In 2024 semaglutide (Wegovy) became the first weight loss drug to also be approved for the reduction of risk of serious cardiovascular events in patients with cardiovascular disease and obesity or overweight
Almost every time I give a talk, theres someone in the audience whos taken [GLP-1] drugs and they say, I just dont feel thirsty anymore, said Derek Daniels, an ingestive behavior researcher at the University at Buffalo
Common ones include mild irritation at the injection site, fatigue, and headache
Whether youre managing type 2 diabetes or struggling with weight loss, you may have heard of medications like Ozempic, Wegovy, or Mounjaro
The resulting unprecedented absorption achieves glutathiones potent antioxidant properties, making it a bioavailable reality